Phage display screening of therapeutic peptide for cancer targeting and therapy

Abstract

Recently, phage display technology has been announced as the recipient of Nobel Prize in Chemistry 2018. Phage display technique allows high affinity target-binding peptides to be selected from a complex mixture pool of billions of displayed peptides on phage in a combinatorial library and could be further enriched through the biopanning process; proving to be a powerful technique in the screening of peptide with high affinity and selectivity. In this review, we will first discuss the modifications in phage display techniques used to isolate various cancer-specific ligands by in situ , in vitro , in vivo , and ex vivo screening methods. We will then discuss prominent examples of solid tumor targeting-peptides; namely peptide targeting tumor vasculature, tumor microenvironment (TME) and over-expressed receptors on cancer cells identified through phage display screening. We will also discuss the current challenges and future outlook for targeting peptide-based therapeutics in the clinics.

Cited by papers we hold 6

• Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines · 2025
  No notice
• Immunotherapy in hematologic malignancies: achievements, challenges and future prospects · 2023
  No notice
• Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy · 2023
  No notice
• Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy · 2022
  Not checked
• Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems · 2022
  No notice
• Molecular Rules Underpinning Enhanced Affinity Binding of Human T Cell Receptors Engineered for Immunotherapy · 2020
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.